SI1781277T1 - Kombinirani sestavek ki vsebuje ibuprofen in paracetamol - Google Patents

Kombinirani sestavek ki vsebuje ibuprofen in paracetamol

Info

Publication number
SI1781277T1
SI1781277T1 SI200531517T SI200531517T SI1781277T1 SI 1781277 T1 SI1781277 T1 SI 1781277T1 SI 200531517 T SI200531517 T SI 200531517T SI 200531517 T SI200531517 T SI 200531517T SI 1781277 T1 SI1781277 T1 SI 1781277T1
Authority
SI
Slovenia
Prior art keywords
paracetamol
ibuprofen
combination composition
combination
composition
Prior art date
Application number
SI200531517T
Other languages
English (en)
Slovenian (sl)
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of SI1781277T1 publication Critical patent/SI1781277T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
SI200531517T 2004-07-07 2005-07-07 Kombinirani sestavek ki vsebuje ibuprofen in paracetamol SI1781277T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ53398204 2004-07-07
EP05764510A EP1781277B1 (en) 2004-07-07 2005-07-07 A combination composition comprising ibuprofen and paracetamol
PCT/NZ2005/000168 WO2006004449A2 (en) 2004-07-07 2005-07-07 A combination composition

Publications (1)

Publication Number Publication Date
SI1781277T1 true SI1781277T1 (sl) 2012-07-31

Family

ID=35783254

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531517T SI1781277T1 (sl) 2004-07-07 2005-07-07 Kombinirani sestavek ki vsebuje ibuprofen in paracetamol

Country Status (21)

Country Link
US (4) US20080275125A1 (cg-RX-API-DMAC7.html)
EP (1) EP1781277B1 (cg-RX-API-DMAC7.html)
JP (1) JP5630943B2 (cg-RX-API-DMAC7.html)
KR (1) KR101370712B1 (cg-RX-API-DMAC7.html)
CN (1) CN101022789A (cg-RX-API-DMAC7.html)
AT (1) ATE543491T1 (cg-RX-API-DMAC7.html)
AU (2) AU2005260243B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0512756A (cg-RX-API-DMAC7.html)
CA (1) CA2570474C (cg-RX-API-DMAC7.html)
CY (2) CY1112738T1 (cg-RX-API-DMAC7.html)
DK (1) DK1781277T3 (cg-RX-API-DMAC7.html)
ES (1) ES2381794T3 (cg-RX-API-DMAC7.html)
GB (1) GB2431346C (cg-RX-API-DMAC7.html)
LT (1) LTC1781277I2 (cg-RX-API-DMAC7.html)
MX (1) MX2007000117A (cg-RX-API-DMAC7.html)
PL (1) PL1781277T3 (cg-RX-API-DMAC7.html)
PT (1) PT1781277E (cg-RX-API-DMAC7.html)
RU (2) RU2007101686A (cg-RX-API-DMAC7.html)
SI (1) SI1781277T1 (cg-RX-API-DMAC7.html)
WO (1) WO2006004449A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700896B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0512756A (pt) 2004-07-07 2008-04-08 Aft Pharmaceuticals Ltd composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas
ZA200803566B (en) * 2005-12-12 2009-10-28 Adcock Ingram Ltd Pharmaceutical compositions
ES2651444T3 (es) * 2006-10-20 2018-01-26 Johnson & Johnson Consumer Inc. Combinación de acetaminofeno con ibuprofeno para el tratamiento del dolor
JP5676834B2 (ja) * 2006-11-29 2015-02-25 エスエス製薬株式会社 消化管への刺激性を減少した経口固形組成物
CA2731801C (en) * 2007-07-23 2013-11-26 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
KR20110065417A (ko) * 2008-01-03 2011-06-15 욱크하르트 리미티드 파라세타몰 및 이부프로펜을 포함하는 경구 약제학적 현탁액
TR201906742T4 (tr) 2008-10-14 2019-05-21 Aft Pharmaceuticals Ltd Tıbbi bir ürün ve tedavi.
DE102010008876B4 (de) 2010-02-22 2017-07-27 Integrated Micro-Electronics Bulgaria Lichtquelle mit Array-LEDs zum direkten Betrieb am Wechselspannungsnetz und Herstellungsverfahren hierfür
NZ604009A (en) * 2010-07-07 2015-03-27 Aft Pharmaceuticals Ltd A combination composition comprising ibuprofen and paracetamol
ES2742373T3 (es) * 2010-11-04 2020-02-14 Aft Pharmaceuticals Ltd Una composición de combinación
BR112013028668A2 (pt) * 2011-05-06 2017-01-24 Glaxosmithkline Llc formulações de paracetamol de liberação sustentada
JP6009928B2 (ja) * 2012-12-14 2016-10-19 ダイハツ工業株式会社 車両のサスペンション
KR102373089B1 (ko) * 2017-03-30 2022-03-11 한미약품 주식회사 이부프로펜 및 아세트아미노펜을 포함하는 약제학적 조성물 및 이의 제조방법
EP4480495A3 (en) * 2017-07-10 2025-06-18 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
WO2019108147A1 (en) 2017-11-29 2019-06-06 İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş. Color stable fixed dose tablet combination of ibuprofen and paracetamol
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
PH12021553169A1 (en) 2019-06-27 2022-08-15 Glaxosmithkline Consumer Healthcare Holdings Us Llc Novel ibuprofen and acetaminophen composition
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
ZA959469B (en) 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
KR970000231A (ko) * 1995-06-12 1997-01-21 박형미 진통소염제의 의약조성물
JP3982889B2 (ja) 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
BRPI0512756A (pt) 2004-07-07 2008-04-08 Aft Pharmaceuticals Ltd composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
TR201906742T4 (tr) 2008-10-14 2019-05-21 Aft Pharmaceuticals Ltd Tıbbi bir ürün ve tedavi.

Also Published As

Publication number Publication date
CY1112738T1 (el) 2016-02-10
ATE543491T1 (de) 2012-02-15
ES2381794T3 (es) 2012-05-31
US20080200549A1 (en) 2008-08-21
CN101022789A (zh) 2007-08-22
EP1781277B1 (en) 2012-02-01
RU2007101686A (ru) 2008-08-20
GB2431346B (en) 2010-01-27
LTPA2024501I1 (cg-RX-API-DMAC7.html) 2024-02-12
WO2006004449A3 (en) 2006-03-02
EP1781277A4 (en) 2008-09-03
GB0700027D0 (en) 2007-02-07
GB2431346C (en) 2010-02-17
CY2023026I2 (el) 2025-03-28
RU2010147287A (ru) 2012-05-27
CA2570474A1 (en) 2006-01-12
CY2023026I1 (el) 2024-02-16
JP5630943B2 (ja) 2014-11-26
DK1781277T3 (da) 2012-05-07
WO2006004449A2 (en) 2006-01-12
US20080275125A1 (en) 2008-11-06
KR20070034614A (ko) 2007-03-28
US20110275718A1 (en) 2011-11-10
PL1781277T3 (pl) 2012-07-31
LTC1781277I2 (cg-RX-API-DMAC7.html) 2024-07-10
MX2007000117A (es) 2007-06-15
BRPI0512756A (pt) 2008-04-08
EP1781277A2 (en) 2007-05-09
AU2008202029A1 (en) 2009-11-26
US20140073696A1 (en) 2014-03-13
GB2431346A (en) 2007-04-25
AU2005260243B2 (en) 2009-10-29
PT1781277E (pt) 2012-05-07
ZA200700896B (en) 2008-07-30
CA2570474C (en) 2010-01-05
RU2455983C1 (ru) 2012-07-20
KR101370712B1 (ko) 2014-03-06
AU2005260243A1 (en) 2006-01-12
JP2008505889A (ja) 2008-02-28
US10532036B2 (en) 2020-01-14

Similar Documents

Publication Publication Date Title
GB2431346C (en) A combination composition comprising paracetamol and ibuprofen
TWI340640B (en) Combination, kit and pharmaceutical composition for treatment of parkinson's disease
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
TW200605870A (en) Topical methadone compositions and methods for using the same
TW200716208A (en) Modified and immediate release memantine bead formulation
MXPA04003666A (es) Uso de flibanserina para tratamiento de trastornos sexuales.
EP1545483A4 (en) NON-NUCLEOSIDIC INHIBITORS OF INVERSE TRANSCRIPTASES
SG166093A1 (en) Inhibitors of brutonæs tyrosine kinase
CY1118179T1 (el) Φαρμακευτικη συνθεση
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
MEP55308A (en) New pharmaceutical compositions containing flibanserin polymorph a
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
EP2161037A3 (en) Camptothecin-Somatostatin conjugates
MXPA06013133A (es) Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina.
NZ591496A (en) A medicinal comprising ibuprofen and paracetamol and treatment for arthritis
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
GEP201606538B (en) Preoperative treatment of post operative pain
SE0203817D0 (sv) New composition
MY154883A (en) A combination composition
MX2009008873A (es) Composicion util para el tratamiento de diabetes tipo 2.
MXPA05005326A (es) Tableta que comprende efletirizina y pseudoefedrina.
PT1572686E (pt) Derivados de amida do ácido antranílico e suas utilizações farmacêuticas
WO2005089762A3 (en) Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition
WO2005011589A3 (en) Drug delivery methods and devices